This article outlines the therapeutic mechanisms of hyperbaric oxygenation in acute stroke, based on information obtained from peer-reviewed medical literature. Hyperbaric oxygen is an approved treatment modality for ischemia-reperfusion injury in several conditions. It maintains the viability of the marginal tissue, reduces the mitochondrial dysfunction, metabolic penumbra, and blocks inflammatory cascades observed in acute stroke. Basic and clinical data suggest that hyperbaric oxygen could be a safe and effective treatment option in the management of acute stroke. Further work is needed to clarify its clinical utility when applied within the treatment window of "gold standard" treatments (<3-5 hours). Key words: acute stroke, hyperbaric oxygenation, ischemiareperfusion injury, mitochondrial dysfunction
Health Statistics 2011 National Health Interview Survey, the number of noninstitutionalized adults who experienced stroke was 6.2 million (2.7%). The number of visits to health institutions with stroke as the primary diagnosis was 3.3 million (2006-2207). The number of patients with stroke as primary diagnosis was 44 800 (3.1%), and there were 45 100 hospice care discharge cases (4.3%). The average length of stay in nonfederal short-stay hospitals was 4.8 days, although, in some hospitals, the length of stay extended up to 10.9 days. [1] [2] [3] Within the Hispanic population, the average years lost before 75 years of age per 100 000 population was 191. The most important risks factors were age (45-64 years), being a married white female with a high school education, having a salary under $35 000, and living in a large metro statistical area of the south.
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period. 2 The extension of the damage depends on the severity, duration, localization, metabolic changes, and comorbidities. [4] [5] [6] [7] 
PATHOPHYSIOLOGY OF THE ISCHEMIA-REPERFUSION INJURY
The core of the pathophysiology of stroke is the ischemia-reperfusion injury to the central nervous system. The injury is the result of a series of ischemic and metabolic events that present shortly after the interruption of flow and nutrients to the affected regions of the brain.
The center of the lesion, or the area of necrosis, is surrounded by an area of vascular edema (penumbra). If the ischemic and metabolic penumbras are not resolved in a timely and effective fashion, the area will be lost both to the ischemia-reperfusion injury and to apoptosis.
The changes due to ischemia and hypoxia in stroke may be reversible or irreversible. There are 7 stages of cellular shock, and the first 4 stages are reversible. Reversibility depends in great measure on the ability of the mitochondria to continue to produce ATP. 8 Once ATP is reduced in the cell beyond a critical level (<1 mol/kg), there is an energy crisis within the cell. 9 There is a dysfunction of the ATPase and the pumps of calciumpotassium and sodium-potassium, creating an ionic misbalance. Right before total mitochondrial dysfunction, the liberation of cytochrome c occurs due to the rise in the level of nitric oxide. This is followed by the opening of the mitochondrial transition pore. The mitochondria fails and frees its calcium content into the cytosol, with concomitant cellular edema and loss of cellular homeostasis. [10] [11] [12] [13] [14] [15] Calcium is the first modulator of the inflammatory cascades (Figure 1) . 16, 17 It stimulates the activation of calcium protease, which enhances the conversion of the xanthine dehydrogenase to xanthine oxidase, which, in turn, enhances the production of reactive oxygen species (ROS). 18 It also stimulates the arachidonic acid cascade, with subsequent elevation in the levels of COX (cyclooxygenase) and lipooxygenase and the production of leukotriene, thromboxane, and prostaglandins. 19 It promotes the expression of a very important transcription factor for inflammation (NFκB) and enhances the production of endothelins and cytokines (IL-1, IL-6, IL-8, IL-10, TNF-α). [20] [21] [22] [23] There is also an elevation in the levels of interpheron γ , glutamate, caspases (3, 8, and 9) , hipoxia induced factor-1α, and nitric oxide (dependent of inducible nitric oxide synthase [iNOS] and neuronal nitric oxide synthase [nNOS]). [24] [25] [26] [27] [28] At the endothelial level, there is an augmentation of the expression of adhesion molecules (selectines, vascular adhesion molecule, intercellular adhesion molecule [ICAM] ) and of the neutrophils (integrin β2). [29] [30] [31] [32] In the late phases of stroke, these adhesion molecules are responsible for most of the damage (80%), promoting production of ROS, apoptosis, and perivenular arteriolar vasoconstriction, which eventually helps establish the no-flow state ( Figure 1 ).
Presently, it is considered that the maintenance of the aerobic cellular metabolism is the keystone of acute stroke management. 17, 33 Stenting, angioplasty, and thrombolytic agents have demonstrated important benefits, especially when applied in the first 3 to 5 hours after stroke. Nevertheless, medication has not shown the same favorable neuroprotective effects as the other therapies.
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HYPERBARIC OXYGEN EFFECTS ON ACUTE STROKE
Hyperbaric oxygen (HBO 2 ) is a treatment option in which a patient breathes 100% oxygen intermittently while inside a treatment chamber at a pressure higher than sea-level pressure (>1.4 atmosphere, absolute [atm abs]). To raise the pressure, a mono-or multiplace chamber is used. 17, 40 Hyperbaric oxygenation is based on gas laws, especially the Henry law. By raising the pressure, the amount of oxygen that is dissolved in plasma and tissues is increased. The normal treatment pressure varies from 1.5 to 3.0 atm abs and lasts from 90 to 120 minutes. The partial pressure that a patient can reach at 3.0 atm abs is close to 2200 mm Hg. This is known as the primary effect of hyperoxygenation. 17, 40 Hyperbaric oxygenation produces several secondary effects. It reduces edema and improves perfusion at the microcirculatory level, 41, 42 promotes wound healing, [43] [44] [45] and stimulates angiogenesis, lymphogenesis, and the production of growth factors. [46] [47] [48] Hyperbaric oxygen has direct and indirect antimicrobial effects. 41, 49 It promotes bone remodeling and induction 50 and has rheological effects that are synergistic with pentoxiphilin. 51 It also reduces hypercoagulation induced by zymozan. 52 Finally, HBO 2 increases mobilization of stem cells from bone marrow. 53, 54 Hyperbaric oxygen reduces cerebral loss of energy and cellular ion homeostasis and diminishes acidosis and increase of cellular calcium. It also limits excitatory and ROS toxicity and ischemia-reperfusion injury. This is accomplished through several mechanisms. First, it increases the oxygen tension and restores oxygen content in all the tissues, including at the cellular level. By this means, it salvages the cerebral ischemic and metabolic penumbra and restores mitochondrial oxidative phosphorylation. 15, 17, 55, 56 The restoration of cellular oxygen tension and mitochondrial function reduces the expression of NFκB and phospholipase A 2 , liberation of calcium, and production of COX-2 mRNA, cytokines (IL-1, IL-6, IL-8, and TNFα), iNOS, and nNOS. Paradoxically, it increases the level of IL-10 (anti-inflammatory cytokine). 17, [57] [58] [59] [60] [61] [62] Hyperbaric oxygen restores the flux of protons (H + ) in the mitochondrial complexes, thereby restoring the production of ATP. This limits the mtDNA damage, expression of caspases, oxidative damage (ROS), expression of the NOGO-A, Ng-R, and RhoA transcription factors and has an antiapoptosis effect by increasing BCL-2, heme oxygenase (HO-1), and heat shock proteins (HSPs 70 and 72). [63] [64] [65] Hyperbaric oxygen reduces the expression of ICAM-1 and integrin β2, with the concomitant reduction of the late phase of the ischemia-reperfusion injury. [66] [67] [68] [69] In addition to the protective effect that HBO 2 provides through restoration and maintenance of oxygenation, it also provides antioxidant protection by inducing selective gene and chaperon production. [70] [71] [72] The antioxidant effects are also provided by the increased enzymatic and nonenzymatic antioxidant protection. Hyperbaric oxygen increases the production of glutathione and cysteine (nonenzymatic protection), SOD (superoxide dismutase) (especially MnSOD, which is intramitochondrial), glutathione peroxidase, and catalase. [70] [71] [72] [73] [74] [75] Hyperbaric oxygen has been used for cerebral ischemia and stroke for more than 40 years. It is one of the conditions in which HBO 2 has been used that has more published articles. Nevertheless, the quality and number of studies have not been able to produce enough sound evidence to place HBO 2 as an accepted adjunct treatment option for acute stroke. 76 There are reports of more than 2000 cases and series of cases. In a 2005 Cochrane review by Bennett and colleagues, 77 3 randomized trials (106 participants) were included. Data could be pooled only for a limited number of clinically important outcomes. There was no significant difference in mortality rate at 6 months (relative risk, 0.61; 95% confidence interval [CI], 0.17-2.2; P = .45). The Trouillas Disability Scale score was lower with HBO 2 (mean difference, 2.2 points; 95% CI, 0.15-4.3; P = .04) and higher with the Orgogozo Scale score (mean difference, 27.9 points; 95% CI, 4.0-51.8; P = .02). The review did not find evidence to show that HBO 2 improves clinical outcomes in acute ischemic stroke (AIS). The favorable evidence found in these 3 randomized controlled studies deemed insufficient to provide clear guidelines. 77 In our experience, we treated 6 continuous patients with an acute stroke. All of them were hospitalized within 6 hours of the event (range, 40 minutes to 6 hours). There were 4 female and 2 male. They were evaluated by magnetic resonance imaging (1.5 Tesla) before and after 5-day treatment (T1-weighted, T2-weighted, and FLAIR [fluid-attenuated inversion recovery]). The protocol used was 1.8 atm abs/90 min twice a day. There was a statistical significant reduction in the stroke volume measured by magnetic resonance imaging. The reduction of the infarct volume was from 528 to 276 mm 3 (P < .006). There was no difference between female and male (odds ratio, 1.0631; 95% CI, 0.7331-1.54) (Figure 2 ).
CRITICAL CARE NURSE IN STROKE AND HBO 2
It is important that nurses understand the burden of stroke as a public health issue in the United States. This will guide them in developing appropriate skills both to care for AIS patients and to educate patients and families about secondary stroke prevention. 78 The American Heart Association/American Stroke Association has published guidelines for the medical management of patients with ischemic stroke and strokes caused by intracerebral hemorrhage and subarachnoid hemorrhage. Nursing and allied health management is not provided in these guidelines. 78, 79 Nurses play a pivotal role in all phases of care for patients with stroke. In the emergency or hyperacute care phase, 80, 81 which includes the prehospital setting and emergency department, and the acute care phase, which includes critical care units, intermediate care units, stroke units, and general medical units. 78 In the emergency or hyperacute care phase, it is recommended to increase the number of patients with stroke who receive timely treatment and educational programs for physicians, hospital personnel, and emergency medical services personnel (class I, level of evidence B). 78 During the acute phase, nursing care should focus on continued stabilization of patients with stroke through frequent evaluation of neurological status, blood pressure management, and prevention of complications. Medical management focuses on establishing the cause of AIS, prevention of treatment-related complications, and evaluation of secondary prevention strategies. There is considerable evidence that dedicated stroke teams, units, 294 CRITICAL CARE NURSING QUARTERLY/JULY-SEPTEMBER 2013 and coordinated care improves clinical outcomes in the acute care phase. 78, [82] [83] [84] Nurses are often responsible for the triage and coordination of care throughout the continuum. 82 Time is critical. 85 Nurses play an important role in obtaining and maintaining stroke center certification, just as they do in The Joint Commission's general hospital accreditation. 78 Coordinated care of the AIS patient results in improved outcomes, decreased lengths of stay, and decreased costs.
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CONCLUSION
Hyperbaric oxygen has been used in stroke management since the early 1960s. 86, 87 There are more than 220 articles published in peer-reviewed journals on the use of HBO 2 in stroke. Nevertheless, there is a need to establish a national and international task force to standardize a treatment protocol to be used in conjunction with other treatment modalities to clarify its real benefit in the management of AIS patients.
All injuries to the body in the first 72 hours present as an ischemia-reperfusion injury; the central nervous system is no exception. 17 The core of this injury is characterized by ischemia, hypoxia, cellular energy, and metabolic crisis. Hyperbaric oxygen cannot alone resolve the ischemic penumbra but deals with the metabolic penumbra.
The timely restoration of the flow with revascularization will resolve the ischemic penumbra but not the metabolic penumbra. To resolve this, it is imperative to use a treatment option that can restore cellular oxygen tensions. This can be accomplished only by the use of HBO 2 .
Hyperbaric oxygen has proven to be beneficial in ischemia-reperfusion injury to other systems, and there is an increasing anecdotal evidence on the beneficial effects of HBO 2 in acute cerebral injury and stroke. The number of publications increases with the years.
The meta-analysis does not provide clear guidelines for practice or clinical benefits. Nevertheless, the HBO field has not produced evidence following the other accepted clinical guidelines, especially applying HBO 2 during the window of opportunity (3-5 hours) and in conjunction with other "state-of-theart" treatments (thrombolytic, angioplasty, and stenting). 88, 89 To accomplish this, hyperbaric chambers should be placed inside the stroke unit areas. The only way to define and prove its possible role in acute stroke is to standardize it as an adjunct treatment option inside the stroke units.
